Brief: MaaT Pharma FY Revenue Of EUR 1 Mln

Maat Pharma SA

28/02/2022 17:08

Feb 28 (Reuters) - MAAT PHARMA SA  MAAT.PA :
    * FY REVENUE 1.0 MILLION EUR
    * AS OF DECEMBER 31, 2021, CASH AND CASH EQUIVALENTS OF
POSITIONS
WERE EUR 43.3 MILLION
    * REVENUES OF EUR 1.0 MILLION IN 2021
    * IN 2021, NEW PATIENTS, MOSTLY SUFFERING FROM
GRAFT-VERSUS-HOST
DISEASE, WERE GRANTED EARLY ACCESS TREATMENT WITH MAAT013
    * TO DATE IN 2022, REQUESTS FOR EARLY ACCESS PROGRAM ARE
FOLLOWING
AS SIMILAR TREND TO THAT OBSERVED IN 2021

Source text for Eikon:  ID:nBw7qBqCza 
Further company coverage:  MAAT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))